New CEO and Head of BD appointed to Penrhos Bio – Jan 2022

New CEO and Head of BD appointed to Penrhos Bio – Jan 2022


Unilever and Innova Partnerships one step closer to
self-cleaning surfaces

Dr Yvonne Davies and Professor Richard Hammond

We are very pleased that Dr Yvonne Davies and Professor Richard Hammond have joined Penrhos Bio full time. Yvonne is Head of Business development and Richard is CEO.

Yvonne brings a wealth of experience to the business from over 15 years of business development experience within fast growing startups, academic centres and established multinational organizations. Yvonne also has over 10 years’ Senior Management experience, including holding CEO positions within several technology startups.

Yvonne commented:

With highly developed commercialization skills, I am experienced in raising growth capital, intellectual property assets licensing, knowledge transfer from external collaborators to internal R&D teams, leading contract negotiations and the identification and development of international strategic commercial partners. I am also looking forward to bringing extensive product development experience to the Penrhos Bio Team’.

Richard Hammond joins as full time CEO from a background that spans veterinary healthcare, academia and commercial pharma, most recently building commercial veterinary businesses.

Richard commented:

Throughout my career, I have seen first-hand the real cost of harmful Biofilms across many contexts. Biofilms are a key factor in many of the global challenges we face today.

With the power and reach of Unilever as our partner, and with an enabling network of universities, testing facilities and advisors, Penrhos Bio is offering a sustainable, low toxicity molecule, inspired by the natural biology of the seaweed and effective against bacteria, algae and fungi in Biofilms; that opportunity is world changing.

I am joining a highly experienced and passionate team at Penrhos Bio, and I am looking forward to bringing my commercial experience to lead and grow the business, whilst enabling the worldwide reach and benefit of the unique new technology for greater societal good’.

Richard and Yvonne join the existing team at Penrhos Bio as our first full time employees, and will help build the value in the business as we enter a new phase of rapid growth and commercial development.

Penrhos Bio Launch Series A raise

Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare…

Read More »